• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC VITEK® 2 YEAST ANTIMICROBIAL SUSCEPTIBILITY TEST AST-YS07 TEST KIT; VITEK® 2 AST-YS07 CARD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC VITEK® 2 YEAST ANTIMICROBIAL SUSCEPTIBILITY TEST AST-YS07 TEST KIT; VITEK® 2 AST-YS07 CARD Back to Search Results
Catalog Number 414967
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Manufacturer Narrative
Device not returned to manufacturer.
 
Event Description
A customer in (b)(6) notified biomerieux of discrepant results associated with vitek 2 ast-ys07 test kit involving voriconazole for one isolate, candida albicans, from an external quality control neqas sample (distribution 3789 - strain 2983).(b)(4) expected voriconazole resistant ( mic >8 mg/l r-) but the customer obtained voriconazole sensitive (<=0.12).Customer results from columbia blood agar were voriconazole mic <=0.125 mg/l s (twice).There was no patient injury or any adverse event associated with this issue.An internal biomerieux investigation was conducted.Broth microdilution (the reference method for voriconazole development) was performed to determine the intended result, compared with ast-ys07 cards.Two (2) different lots of ast-ys07 cards from sda and cos bmx media.Broth microdilution provided a voriconazole mic >16 mg/l r.On vitek 2, biomerieux obtained results as follows: from sda media and on two (2) ast-ys07 lots: voriconazole mic = 1 s.From cos media and on one (1) ast-ys07 lot: voriconazole mic <=0.125 s.Vitek 2 voriconazole results (<=0.125 - 1 mg/l s) are essential agreement errors (gap >2 doubling dilutions with the reference mic).Biomerieux duplicated the customer's results.Complaint history was reviewed with no trends noted.The investigation concluded the discrepancy involved an atypical strain.In addition, in the final report from (b)(4), voriconazole was not graded since the level of concordance voriconazole (59%) did not reach the requisite 80% of participants.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® 2 YEAST ANTIMICROBIAL SUSCEPTIBILITY TEST AST-YS07 TEST KIT
Type of Device
VITEK® 2 AST-YS07 CARD
Manufacturer (Section D)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer (Section G)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer Contact
ryan lemelle
595 anglum road
hazelwood, MO 63042
3147318582
MDR Report Key5620602
MDR Text Key44129435
Report Number1950204-2016-00051
Device Sequence Number1
Product Code NGZ
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K092454
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial
Report Date 04/21/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/12/2017
Device Catalogue Number414967
Device Lot Number287368220
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/21/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/18/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-